Steve received his MD from the University of Newcastle Upon Tyne, UK and worked in the UK National Health Service for 17 yrs. He joined Eli Lilly in 2001 and has worked in pharmacovigilance since 2005 in various roles in both the UK and USA. In his current role, Steve has management responsibility for the Senior Directors, physicians and scientists across all therapeutic areas for safety surveillance, benefit risk assessments and risk management/ risk minimization activities.